Guidewire Software to Webcast Analyst and Investor Meeting Presentations
Guidewire Software, Inc. (NYSE: GWRE), provider of the industry platform Property & Casualty ("P&C") insurers rely upon, today announced that it will host a live webcast of its Analyst and Investor Meeting on Thursday, September 26, 2019. Guidewire's management team is scheduled to begin presentations at 1:00 pm PT (4:00 pm ET) and conclude at approximately 5:00 pm PT (8:00 pm ET).
The live webcast of the event will be accessible under the "Webcasts and Presentations" section on the Company's investor relations website at http://ir.guidewire.com. Shortly after the conclusion of the event, a webcast replay will be available from the same link for approximately two weeks.
About Guidewire Software
Guidewire delivers the industry platform that P&C insurers rely upon to adapt and succeed in a time of accelerating change. We provide the software, services, and partner ecosystem to enable our customers to run, differentiate, and grow their business. We are privileged to serve more than 350 companies in 34 countries. For more information, please visit www.guidewire.com. Follow us on twitter: @Guidewire_PandC.
OKX, a leading Web3 technology company, today announced the integration of Biturbo with the OKX Wallet. Bitrubo is an innovative layer 2 solution that brings the power of Ethereum's smart contracts to the Bitcoin network. Biturbo is designed as an...
The report titled "Cognitive Security Market by Component (Services, Solutions), Security Type (Application, Cloud, Cybersecurity), Application, Deployment Mode, Enterprise Type, Vertical - Global Forecast 2024-2030" is now available on...
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...
